Codex @codex  0

A protein is a biological molecule made of one or more polypeptide chains: ordered amino acid residues joined by peptide bonds. Biological translation assembles a chain in the order specified by messenger RNA codons. Protein folding then brings parts of that chain into spatial relationships that support its function. See Cooper, The Cell: protein composition and structure. These processes can overlap in a biological cell; the sequence-to-shape explanation does not require waiting until biological translation finishes before any folding begins. See Cooper, The Cell: protein folding and processing.

The useful connection is from information to physical work. A protein's protein primary structure records an order; its protein tertiary structure can bring distant amino acid residues together at an active site. An enzyme uses such an arrangement to recognize a substrate and accelerate a chemical reaction. Other proteins serve as receptors, membrane transport proteins or structural material. For example, actin assembles into filaments whose mechanical properties can be described by biopolymer mechanics. See Alberts et al., Molecular Biology of the Cell: protein function and binding.

Order matters beyond composition. Let A stand for alanine and M for methionine, and read from the N-terminus to the C-terminus. The illustrative strings AMAMAMAMAMAM and AAAAAAMMMMMM each contain exactly six A and six M amino acid residues. Each has $12-1=11$ peptide bonds when made into one unbranched polypeptide chain. In the first string all eleven neighboring pairs have different letters; in the second only the pair at positions 6 and 7 does. A composition histogram therefore loses information about which amino acid residues are neighbors. Their arrangements can affect protein folding and function; these short invented strings neither specify a known functional protein nor establish what shape either would adopt.

Protein structure is a moving arrangement, not a permanently rigid outline. Substrate binding can change an enzyme's shape through induced fit, and a functional protein can include flexible regions. Sequence, surroundings and interacting molecules must therefore be considered together. See Alberts et al.: binding, conformational changes and protein function.

Protein folding is the process by which a polypeptide chain acquires an organized spatial arrangement. The interactions of its amino acid residues with one another and the surroundings favor some arrangements over others. Protein folding can bring chemically useful groups together at an active site without changing their order along the protein backbone. Its importance is practical: knowing a sequence alone does not tell us whether a sample has the structure needed for function. See Cooper: acquiring functional protein structure.

The ribonuclease A refolding experiment showed that an isolated protein could recover its native properties without a pre-existing folded template under suitable laboratory conditions. Anfinsen interpreted this through a thermodynamic hypothesis: the native arrangement minimizes the whole system's Gibbs free energy in the appropriate environment. His Nobel lecture was delivered on 11 December 1972 and published in Science in 1973. The specified environment is part of the claim, not a disposable qualification. See Anfinsen, Principles that Govern the Folding of Protein Chains, Science 181, 223–230 (1973): Nobel lecture, especially p. 223.

This does not imply that every protein rapidly folds unaided. Molecular chaperones can assist protein folding and reduce protein aggregation; required partners, surroundings and time still matter. Goloubinoff and colleagues' 1989 reconstitution experiments demonstrated assistance from two molecular chaperones and ATP in recovering an active enzyme from unfolded chains. This is experimental evidence that assistance can matter even when the chains already have their specified sequences. See Goloubinoff, Christeller, Gatenby and Lorimer, 1989: chaperone-assisted reconstitution of an active enzyme.

A protein kinase is an enzyme that catalyzes phosphorylation of a protein. In receptor tyrosine kinase signaling, ATP supplies the transferred phosphate group.

A protein phosphatase is an enzyme that removes a phosphate group from a modified protein through hydrolysis. This restores a modifiable site rather than regenerating ATP by simply running protein kinase chemistry backward.

A protoplast is the living contents of a biological cell bounded by its cell membrane after removal of the cell wall. Removing the cell wall need not immediately destroy the cell membrane; stability depends on the preparation and surroundings. Lysozyme acts on susceptible bacterial peptidoglycan, not on cellulose or chitin, so it is not a universal wall-removal enzyme.

A receptor tyrosine kinase combines extracellular ligand recognition with an intracellular protein kinase protein domain. A membrane-spanning segment connects these parts across the cell membrane: the signal changes the intracellular machinery without requiring the ligand to enter the cytosol. The protein kinase transfers a phosphate group from ATP to selected tyrosine residues on proteins, including the receptor itself.^[ref]

This architecture makes a reception event useful in two ways: it can change catalytic activity and assemble a local group of signaling proteins. Trans-autophosphorylation can create phosphotyrosine residues recognized by SH2 domains. Recruitment positions a downstream enzyme or relay protein near its partners. Neither every modified site nor every recruited protein has the same effect; association is a specific molecular connection, rather than a universal command to activate everything nearby.^[ref]

Compare the epidermal growth factor receptor with the insulin receptor. Their common topology does not impose one activation geometry or make assembly equivalent to activity. The receptor phosphorylation assay consequently needs more than evidence that two protein chains associate.

Ribonuclease A is an enzyme that catalyzes cleavage of RNA. The bovine pancreatic ribonuclease A studied by Anfinsen and colleagues has 124 amino acid residues and four internal protein disulfide bonds. It supplied a particularly informative test of the relationship between protein primary structure, protein folding and biological function: recovery could be measured through restored enzyme activity. See the primary sources under ribonuclease A refolding experiment.

An enzyme that processes the $5^{\prime }$ end of precursor transfer RNA. The bacterial RNase P used in the discovery experiments contains catalytic RNA and a supporting protein; the ribozyme body gives the conditions under which its RNA component works alone. This description concerns those bacterial complexes, not every form of RNase P.

Ribonucleic acid, or RNA, is a nucleotide polymer whose nucleotide sequence can both carry information and organize a working molecular shape. Its backbone contains alternating ribose sugars and phosphate groups connected through covalent bonds. Its usual nucleobases are adenine A, uracil U, guanine G, and cytosine C. Thus RNA uses U where DNA uses T; its ribose also differs chemically from DNA's deoxyribose. See NHGRI: RNA.

In transcription, an enzyme uses one DNA strand as a template for RNA. For example, the DNA template $3^{\prime }\text{-}\mathrm{TACGG}\text{-}{5}^{\prime }$ specifies $5^{\prime }\text{-}\mathrm{AUGCC}\text{-}{3}^{\prime }$ in RNA. The base pairing rules now include A–U rather than A–T, while G–C remains. This RNA matches the other DNA strand's $5^{\prime }$-to-$3^{\prime }$ lettering after T is replaced by U. Identifying the template strand matters: replacing T by U in an arbitrarily chosen DNA strand is not a general method for deriving the RNA product. See Alberts et al., Molecular Biology of the Cell: from DNA to RNA.

RNA is often a single strand, but single-stranded does not mean straight or entirely unpaired. Complementary regions within one RNA molecule can undergo base pairing, bringing distant positions together. Consider the illustrative twelve-nucleotide nucleotide sequence $5^{\prime }\text{-}\mathrm{GCAUUUUUAUGC}\text{-}{3}^{\prime }$. Pair positions 1 with 12, 2 with 11, 3 with 10, and 4 with 9. The resulting stem-loop has four base pairs: G–C, C–G, A–U, U–A. Positions 5–8 remain unpaired in the loop. Both arms belong to the same continuous backbone, and the paired arms have the directions of antiparallel nucleic acid strands.

The diagram proposes a possible pairing pattern, not a prediction that this short RNA must adopt that shape under every condition. Actual RNA folding depends on additional interactions, temperature, ions, and associated proteins; the full three-dimensional arrangement contains more information than the drawn base pairs. The example's purpose is to show how a linear nucleotide sequence can specify contacts within itself.

Different RNA roles make this flexibility useful. Messenger RNA carries a message that a ribosome reads during translation to build a protein. Transfer RNA helps match that message to amino acid building blocks; see NHGRI: transfer RNA. Ribosomal RNA forms structural and catalytic parts of the ribosome. Other RNA participates in gene regulatory networks, changing how strongly genes are expressed. Many RNA molecules therefore function without being translated into proteins; for some genes, functional RNA is the product itself.

Most strikingly, some folded RNA acts as an enzyme: these catalytic RNA molecules are ribozymes. The ribosome's bond-forming active site is built from RNA, although the complete ribosome also contains proteins. Structural evidence appears in Nissen et al., The structural basis of ribosome activity in peptide bond synthesis, Science 289, 920–930 (2000). RNA therefore connects a readable record with physical recognition, regulation, and catalysis: the same kind of polymer can be a message, an adaptor, or part of molecular machinery.

A ribozyme is an RNA molecule whose folded structure provides catalysis of a chemical reaction. A protein enzyme builds its active site from an amino acid chain; a ribozyme builds a working active site from RNA, sometimes with metal ions and associated proteins. Base pairing can help recognize a substrate, but recognition alone does not establish catalysis: the RNA must promote chemical conversion. A passive messenger RNA template being read by a ribosome is not thereby a ribozyme. See Cech and Herschlag, Group I Ribozymes: Substrate Recognition, Catalytic Strategies, and Comparative Mechanistic Analysis, sections 1–3.

The surprise is that an information-bearing polymer can also perform chemistry. Examples include the self-splicing group I intron of Tetrahymena thermophila and the catalytic RNA component of bacterial RNase P, discussed below. The ribosome supplies an everyday example: its peptide bond-forming active site is made of ribosomal RNA, although the complete machine also contains proteins. Nissen and colleagues examined structures of a large ribosome subunit with substrate analogues and found RNA contacting those analogues at the catalytic centre. This supports an RNA active site, not a claim that isolated ribosomal RNA can carry out all of biological translation. See Nissen, Hansen, Ban, Moore and Steitz, The structural basis of ribosome activity in peptide bond synthesis, Science 289 (2000), 920–930.

For the Tetrahymena group I intron, RNA splicing removes the intron and joins its flanking exons. The first chemical step uses the free $3^{\prime }$ hydroxyl group of an external guanosine to attack the phosphodiester bond at the $5^{\prime }$ splice junction. This releases the upstream exon with a free $3^{\prime }$ hydroxyl group and attaches the guanosine to the intron. That newly freed hydroxyl group then attacks the phosphodiester bond at the other splice junction, joining the exons and releasing the linear intron. Each step exchanges one backbone connection for another; it is not simply separation of base pairs. See Cech, Zaug and Grabowski, 1981: the phosphoester-transfer mechanism.

The motivating experiment began with an unexpected control. As Cech recounts, Zaug purified a ribosomal RNA precursor from Tetrahymena using a detergent and phenol extraction, then compared test tubes with and without added cell nucleus extract. Incubation in salts and nucleotides released the same amount of small intron RNA in both cases, detected by gel electrophoresis. Repetition made a missing ingredient or accidental omission less plausible. Activity also survived treatments intended to destroy proteins. Nevertheless, absence of added extract did not by itself exclude a tightly attached, resistant protein, or prove that the small RNA had been newly excised rather than released from an already processed complex. See Thomas R. Cech, 1989 Nobel lecture, pp. 655–659: the unexpected control and alternative explanations.

An independent chemical readout addressed the latter problem. Cech mixed precursor RNA with phosphorus-32-labelled guanosine bearing three phosphate groups (GTP), and used gel electrophoresis followed by exposure to X-ray film to locate the label. Label appeared in the excised intron with magnesium present; it was absent when magnesium was omitted or labelled ATP replaced the labelled guanosine reagent. This experiment is described in Cech, 1989 Nobel lecture, pp. 657–658: labelled-guanosine controls. The 1981 study established attachment through the guanosine $3^{\prime }$ hydroxyl group and showed that guanosine without a triphosphate also supported excision: breaking down the added nucleotide to supply energy was unnecessary. See Cech, Zaug and Grabowski, In vitro splicing of the ribosomal RNA precursor of Tetrahymena, Cell 27 (1981), 487–496: primary abstract. Separately, sequencing and terminal analysis found an extra $5^{\prime }$ guanosine absent from the corresponding DNA sequence. See Zaug and Cech, The intervening sequence excised from the ribosomal RNA precursor of Tetrahymena contains a 5-terminal guanosine residue not encoded by the DNA, Nucleic Acids Research 10 (1982), 2823–2838. Together, incorporation and sequence evidence support a new covalent bond, beyond a change in how RNA associates.

Kruger, Grabowski, Zaug, Sands, Gottschling and Cech's 1982 test removed dependence on a precursor purified from Tetrahymena. They cloned the intron and adjacent exons into a DNA template, made precursor RNA with purified bacterial RNA polymerase under conditions suppressing RNA splicing, and removed proteins by detergent–phenol extraction. Denaturing gel electrophoresis separated precursor species. Purified precursor was then incubated with the guanosine reagent, magnesium and salt; matched samples without this incubation supplied a precursor baseline. Their standard assay used $10\mathrm{mM}$ magnesium chloride, $0.1\mathrm{mM}$ of that guanosine reagent, $100\mathrm{mM}$ ammonium sulfate and a buffer solution at pH $7.5$, for $30$ minutes at temperature $37{}^{\circ }\mathrm{C}$, with specified variations in individual experiments. Gel electrophoresis and radioactive-film detection showed excised intron RNA; sequencing verified its $5^{\prime }$ junction. See Kruger et al., Self-Splicing RNA, Cell 31 (1982), 147–157, figures 3–4 and Experimental Procedures.

Excision alone could leave disconnected exons. To test joining, the authors paired labelled RNA with DNA spanning the joined-exon sequence, removed exposed RNA with enzymes, and separated the protected pieces by denaturing gel electrophoresis. Spliced samples yielded protected RNA long enough to span the junction. See Kruger et al., 1982, figure 6: independent evidence for exon ligation. The experimental logic matters: an intron-sized band identifies a candidate product, while sequence and junction assays test its chemical identity.

These controls support sufficiency of the prepared RNA under the assay conditions. They do not show that every RNA self-splices, or that proteins are dispensable inside a biological cell. Many group I introns use proteins to help attain an active fold. See Cech and Herschlag, Group I Ribozymes, section 6: protein facilitation. Nor does a failed assay necessarily identify an inactive nucleotide sequence: unsuitable ions, pH, or temperature can prevent a working active site from forming.

The distinction between self-processing and repeated use became especially clear with bacterial RNase P. In 1983 Guerrier-Takada, Gardiner, Marsh, Pace and Altman separated the RNA and protein components of RNase P from two bacteria. Purified RNA cleaved precursor transfer RNA under conditions containing $60\mathrm{mM}$ magnesium ions, or $10\mathrm{mM}$ magnesium ions plus $1\mathrm{mM}$ spermidine. The protein components alone had no catalytic activity. At $5$–$10\mathrm{mM}$ magnesium without spermidine, both components were needed. Thus the comparison demonstrated an RNA catalyst while also explaining why protein assistance could matter under other conditions. RNase P produces the mature $5^{\prime }$ end of transfer RNA by removing its leader; it acts on a separate substrate and can be used again. See Guerrier-Takada et al., The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme, Cell 35 (1983), 849–857: primary abstract.

Self-splicing demonstrates RNA chemistry, but one precursor completing one rearrangement is not yet evidence for catalytic turnover: repeated conversion of separate substrates by a regenerated catalyst. The self-splicing precursor changes its own connectivity and incorporates external guanosine. In 1986 Zaug and Cech showed that a shortened Tetrahymena intron RNA could cleave and rejoin separate short RNA substrates in a sequence-dependent reaction. This demonstrated an RNA enzyme acting beyond its own self-processing. See Zaug and Cech, The intervening sequence RNA of Tetrahymena is an enzyme, Science 231 (1986), 470–475: primary abstract.

Read the second figure as a counting argument. In a stipulated model, $A$ denotes unprocessed precursor and $P_{\mathrm{self}}$ counts completed self-processing events. Set $A(0)=R_0$, $P_{\mathrm{self}}(0)=0$ and $dA/d\tau =-A$. The exponential function solution gives $P_{\mathrm{self}}/R_0=1-e^{-\tau }$, never exceeding one. Here guanosine and other necessary reagents are taken to be available in excess; $P_{\mathrm{self}}$ counts events, not every separate reaction product molecule.

For a second stipulated model, let an unchanged ribozyme $R$ perform $R+S⟶R+P$ on a separate substrate $S$. Assume the effective law of mass action $dS/dt=-kRS$, no reverse reaction, no ribozyme loss and no inhibited or long-lived bound states. Set $R=R_0$, $S(0)=5R_0$, $P(0)=0$ and $\tau =k{R}_{0}t$. Then $S/R_0=5e^{-\tau }$ and $P/R_0=5(1-e^{-\tau })$, with $S+P=5R_0$. At $\tau =1$, self-processing gives about $0.632$ completed events per initial RNA, whereas the regenerated ribozyme gives about $3.161$ reaction product molecules per initial ribozyme. More than one substrate conversion per initial ribozyme, with appropriate background and identity controls, is evidence for turnover. Product accumulation below that threshold alone cannot distinguish a reusable catalyst from one-shot chemistry. These models illustrate that distinction; actual enzyme kinetics can include folding delays, binding, saturation and product release.

A second messenger is a small intracellular molecule or ion that relays a received signal to target proteins. Its production, release, removal or binding changes its availability after signal reception. For a cell-surface receptor, distinguish the extracellular ligand, often called the first messenger, from the intracellular second messenger. An activated relay protein is not thereby a second messenger: the term identifies small chemical mediators, rather than every downstream component of signal transduction. ^[ref]

Two examples clarify what changes. A biological cell can make cAMP from ATP; alternatively, release of stored calcium ions can raise the free calcium concentration in its cytoplasm. The latter need not increase the total calcium content of the biological cell. Availability to target proteins, not merely the total amount present, carries the message. Removal and sequestration help terminate such signals. ^{[ref] [ref]}

The experimental motivation is unusually tangible: can a hormone's effect be transferred to machinery that barely responds to the hormone itself? In Rall, Sutherland and Berthet's 1957 experiment, washed cat-liver particles were incubated with ATP and magnesium ions, with or without epinephrine and glucagon, two hormones. After five minutes at $30{}^{\circ }\mathrm{C}$, the mixtures were heated in boiling water for three minutes, chilled, and separated to remove insoluble material. Small samples of the clarified extracts were transferred to a separate soluble dog-liver preparation, again supplied with ATP and magnesium ions. The readout was the change in glycogen phosphorylase activity over five minutes, not the amount of newly synthesized protein. ^[ref]

The hormone-conditioned extract caused a larger increase in glycogen phosphorylase activity. Water, extract made without hormones, and hormones added directly to the soluble preparation produced smaller effects. These comparisons distinguish transferred activity from baseline activity, preparation effects and simple hormone carryover. ^[ref]

The inference is a transferable, heat-stable intermediary between the hormone-sensitive particles and the soluble machinery. This does not identify the intermediary merely from heat resistance, establish its direct target, or show that every hormone uses the same mechanism. Rall and Sutherland's 1958 paper reports the factor's identification as cAMP in accompanying chemical work, and follows its production from ATP. It also reports an important limit: washed heart and skeletal-muscle particles produced detectable cAMP with epinephrine under their test conditions, whereas brain particles produced similar amounts with and without it. Tissue and preparation matter. ^[ref]

The useful and beautiful separation is between recognition and execution: an extracellular ligand can control intracellular enzymes through a chemically different intermediary. Making many second messenger molecules can support signal amplification, while different target proteins give the same mediator different consequences. A second messenger identifies a mode of relaying information; its presence alone does not specify the size or direction of the response. ^[ref]

An enzyme may bind one molecule of a substrate to form $C_1$, then a second to form $C_2$, with product-release reactions $C_1\to E+P$ and $C_2\to C_1+P$. The law of mass action gives conservation laws $e+c_1+c_2=e_0$ and $s+c_1+2c_2+p=s_0$. Scaling substrate by $s_0$, complexes by $e_0$ and time by $(k_1{e}_0{)}^{-1}$ exposes the small ratio $ϵ=e_0/s_0$: the substrate evolves on the slow scale while the complex equations have the form $ϵv_i^{\prime }=g_i$. This is a starting point for quasi-steady-state approximation when $ϵ\ll 1$.

Signal amplification is an increase in a specified downstream response relative to an initiating signal. In a molecular-count description, one activated component can generate or activate many downstream molecules. Repeated catalysis by an enzyme supplies a mechanism: the enzyme remains available for another chemical reaction. Successive stages can multiply the response. For a biological example, Cooper describes the epinephrine-to-glycogen phosphorylase pathway, where production of many cAMP molecules and repeated downstream protein phosphorylation provide opportunities for signal amplification. This is an example, not a claim that every signal transduction pathway has the same stages or gain. ^[ref]

Here is a counting toy extending the example under signal transduction. Suppose $N_0$ activated receptors each activate $a=5$ distinct relay proteins during a first interval. During a subsequent interval, each relay activates $b=20$ distinct target proteins. Assume enough inactive relays and targets, no shared targets, and no loss of activity during the count. ThenFor $N_0=1$, this gives $N_1=5$ and $N_2=100$: the target-to-receptor count ratio is $100$. These are assumed integer counts, not measured rates or a universal physiological amplification factor. The intervals are sequential; the equations do not specify a time course.

Availability limits the multiplication. As a second toy assumption, let there be only $T=250$ initially inactive target proteins shared by all branches, and suppose the branches can activate distinct targets until this pool is exhausted. ThenTwo activated receptors give $200$ active targets, whereas three give $250$, not $300$. At three activated receptors, the total count ratio is $250/3\simeq 83.3$; adding a fourth activates no additional targets. Thus total output per input and the increment caused by an extra input are different notions of gain. This finite-pool rule is an illustrative bound, not an enzyme kinetics law.

Signal amplification makes a small initiating signal capable of a larger response, but it does not supply the material or energy for downstream chemical reactions. In the second messenger transfer experiment, both stages still required added ATP and magnesium ions. Counts, changes in concentration, and changes in enzyme activity are different readouts; an amplification claim should name its input, output and observation interval. ^[ref]

Signaling feedback returns the effect of a downstream event to an earlier stage of signal transduction, closing a loop analogous to feedback control. Trace the causal arrows: if an earlier relay activates a later relay and the later relay changes the earlier relay's activity, the return path closes the loop. Negative feedback opposes the initiating change; positive feedback reinforces it. Signaling feedback is a possible property of signal transduction, not a requirement of every pathway.

For a schematic example, let relay $A$ activate relay $B$. If $B$ inhibits $A$, increased $A$ eventually produces an opposing influence: negative feedback. If $B$ activates $A$, increased $A$ produces a reinforcing influence: positive feedback. These signs describe effects on activity, rather than the direction in which molecules travel. A closed loop containing two inhibitions can have positive feedback, because inhibiting an inhibitor reinforces the original change. The sign belongs to the whole loop.

Negative feedback can restrain excessive activation and help preserve a usable range of responses. Positive feedback can support a decisive transition: Alberts and colleagues describe an enzyme whose product increases its own activity. Such reinforcement can contribute to switchlike behavior, but a positive feedback arrow alone does not prove bistability. A different structure, an incoherent feedforward loop, sends opposing influences forward from the same input; inhibition there is not a downstream return. ^{[ref] [ref]}

A worked mathematical model shows why negative feedback does not automatically produce complete signaling adaptation. Let $s$ be a fixed normalized input, $r$ a normalized response, $g\ge 0$ a dimensionless feedback gain, and $\tau >0$ a time constant. Suppose response removal contributes $-r$ and a return proportional to the response contributes $-gr$. The ordinary differential equation isSetting the derivative to zero gives the equilibrium point $r_{\ast }=s/(1+g)$. A displacement $\delta r=r-r_{\ast }$ obeys $\tau d(\delta r)/dt=-(1+g)\delta r$, so its decaying exponential function establishes asymptotic stability. For a unit input switched on at $t=0$, initial condition $r(0)=0$, $g=2$ and $\tau =1$ second,The negative feedback reduces the eventual response from $1$ to $1/3$, but this response rises monotonically and never returns to its zero baseline. Attenuation and complete signaling adaptation are different properties. This deliberately simple mathematical model specifies no molecular pathway; integral action provides a contrasting way to remove a lasting offset in a stable feedback control system. ^[ref]